Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

Movement Disorders

Volumn 13, Issue 2, 1998, Pages 221-227

  Banati, Richard B ^a,b   Daniel, Susan E ^b,c   Blunt, Stavia B ^a,d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cell death mechanisms; DNA fragmentation; Microglia; Parkinson's disease

Indexed keywords

CELL MARKER; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; AGED; AGING; APOPTOSIS; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN STEM; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; MICROGLIA; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; APOPTOSIS; ASTROCYTES; DNA FRAGMENTATION; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MICROGLIA; MULTIPLE SYSTEM ATROPHY; NEUROGLIA; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0031930771     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130205     Document Type: Article

References (21)

1. Forno LS, Alford EC. The pathology of parkinsonism. In: McDowell FH, Markham CH, eds. Recent Advances in PD. Oxford: Blackwell, 1971:120-161.
2. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-1291.
3. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 1994;344:796-798.
4. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in PD. Lancet 1989;1:1269.
5. Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in postmortem parkinsonian brain. Lancer 1987;2:1219-1220.
6. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AH. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to PD. J Neurochem 1994;63:1987-1990.
7. Ziv I, Melamed E, Nardi N, et al. Dopamine induces apoptosis-Iike cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in PD. Neurosci Lett 1994;170:136-140.
8. Walkinshaw G, Waters CM. Induction of apoptosis in catechol-aminergic PC12 cells by L-dopa. Implication for the treatment of PD. J Clin Invest 1995;95:2458-2464.
9. Calne DB. Is idiopathic parkinsonism the consequence of an event or a process? Neurology 1994;44:5-10.
10. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Laboratory Investigation 1994;71:219-225.
11. Graeber MB, Bise K, Meharin P. CR3/43, a marker for activated microglia: application to diagnostic neuropathology. Neuropathol Appl Neurobiol 1994;20:406-408.
12. Gehrmann J, Banati RB. Microglial turnover in the injured CNS: activated microglia undergo delayed DNA-fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 1995;54:680-688.
13. Graeber MB, Streit WJ, Buringer D, Sparks DL, Kreutzberg GW. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J Neuropathol Exp Neurol 1992;51:303-311.
14. Fearnley JM, Lees A. Aging is not involved in the pathophysiology of PD. Brain 1991;114:2283-2301.
15. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 1994;53:606-616.
16. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995;15:3775-3787.
17. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 1995;89:35-41.
18. Wyllie AH, Kerr JFR, Currie AR. Cell death: significance of apoptosis. Int Rev Cytol 1980;68:251-306.
19. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease [Abstract]. Neurology 1996;46(suppl):A467.
20. 18F-DOPA PET study [Abstract]. Journal of Neurochemistry 1994;8(suppl 1):198.
21. Banati RB, Graeber MB. Surveillance, intervention and cytotoxicity: is there a protective role of microglia. Dev Neurosci 1994;16:114-127.